Common virus may hold key to safer kidney transplants

This study looked at whether levels of a common, harmless virus (Torque Teno virus) in the blood can predict infections or organ rejection in kidney transplant recipients who are on stable anti-rejection medication. Researchers followed 172 patients for at least a year, measuring virus levels and tracking health events. The goal was to see if this virus could serve as a simple biomarker to help doctors personalize immunosuppression and improve long-term outcomes.